DIABIO.ST
Price:
$0.0145
Market Cap:
$20.20M
Diagonal Bio AB operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was founded in 2020 and is headquartered in Lund, Sweden.
Industry
Biotechnology
IPO Date
2021-07-16
Stock Exchange
STO
Ticker
DIABIO.ST
According to Diagonal Bio AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 1.94. This represents a change of 6.79% compared to the average of 1.82 of the last 4 quarters.
The mean historical Current Ratio of Diagonal Bio AB (publ) over the last ten years is 4.12. The current 1.94 Current Ratio has changed 4.61% with respect to the historical average. Over the past ten years (40 quarters), DIABIO.ST's Current Ratio was at its highest in in the September 2021 quarter at 15.90. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
4.12
Median
3.70
Minimum
0.65
Maximum
10.00
Discovering the peaks and valleys of Diagonal Bio AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 170.30%
Maximum Annual Current Ratio = 10.00
Minimum Annual Increase = -87.50%
Minimum Annual Current Ratio = 0.65
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.03 | 57.29% |
| 2023 | 0.65 | -87.50% |
| 2022 | 5.22 | -47.82% |
| 2021 | 10.00 | 170.30% |
The current Current Ratio of Diagonal Bio AB (publ) (DIABIO.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.30
5-year avg
4.12
10-year avg
4.12
Diagonal Bio AB (publ)’s Current Ratio is greater than Amniotics AB (publ) (1.17), greater than Idogen AB (publ) (1.67), less than Pharmiva AB (publ) (5.46), greater than AegirBio AB (publ) (0.36), greater than Ziccum AB (publ) (0.36), less than Cyxone AB (publ) (4.01), greater than Learning 2 Sleep L2S AB (publ) (0.14), less than VibroSense Dynamics AB (5.91), less than Pharmacolog i Uppsala AB (publ) (2.28), less than Redwood Pharma AB (5.39),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.17 | $14.76M | |
| 1.67 | $12.79M | |
| 5.46 | $12.93M | |
| 0.36 | $15.43M | |
| 0.36 | $8.56M | |
| 4.01 | $6.75M | |
| 0.14 | $11.68M | |
| 5.91 | $12.70M | |
| 2.28 | $10.70M | |
| 5.39 | $3.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diagonal Bio AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Diagonal Bio AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Diagonal Bio AB (publ)'s Current Ratio?
How is the Current Ratio calculated for Diagonal Bio AB (publ) (DIABIO.ST)?
What is the highest Current Ratio for Diagonal Bio AB (publ) (DIABIO.ST)?
What is the 3-year average Current Ratio for Diagonal Bio AB (publ) (DIABIO.ST)?
What is the 5-year average Current Ratio for Diagonal Bio AB (publ) (DIABIO.ST)?
How does the current Current Ratio for Diagonal Bio AB (publ) (DIABIO.ST) compare to its historical average?